A Study to Evaluate the Pharmacokinetics of Adalimumab in Combination With Methotrexate for the Treatment of Patients With Ulcerative Colitis
Phase of Trial: Phase IV
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Ulcerative colitis
- Focus Pharmacodynamics; Pharmacokinetics
- 07 Jun 2017 Biomarkers information updated
- 12 May 2016 Planned End Date changed from 1 May 2015 to 1 Nov 2017.
- 12 May 2016 Planned primary completion date changed from 1 Nov 2015 to 1 May 2017.